Health Cor Management, L.P. Myriad Genetics Inc Transaction History

Health Cor Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	BUY	$27.23 - $45.56 $1.59 Million - $2.66 Million	58,335 New	58,335 $2.18 Million
Q3 2018 Nov 15, 2018	SELL	$37.57 - $50.34 $2.19 Million - $2.94 Million	-58,335 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$27.75 - $40.17 $1.62 Million - $2.34 Million	58,335 New	58,335 $2.18 Million

254

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.3B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Health Cor Management, L.P. with notifications on news.